Suchergebnisse - "Pembrolizumab"

PubPharm (7.696)

1

Contribution of tumour and immune cells to PD-L1 expression as a predictive biomarker in metastatic triple-negative breast cancer : exploratory analysis from KEYNOTE-119

enthalten in: The journal of pathology. Clinical research | 2024

von Cortes, J. | Winer, E. | Lipatov, O. | +18

2

Association Between Kidney Function and Outcomes Following Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Carcinoma

enthalten in: Clinical genitourinary cancer | 2024

von Ishihara, H. | Nemoto, Y. | Tachibana, H. | +9

3

Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer

enthalten in: Lung | 2024

von Ramoni, D. | Coco, S. | Rossi, G. | +14

4

Intrahepatic Cholangiocarcinoma With Extrahepatic Metastasis and High Tumor Mutation Burden : Case of Complete Pathological Response to Cisplatin/Gemcitabine/Pembrolizumab

enthalten in: JCO precision oncology | 2024

von Robinson, M. | Wheatley, R. | Foster, L. | +6

5

Impact of neoadjuvant pembrolizumab adherence on pathologic complete response in triple-negative breast cancer : a real-world analysis

enthalten in: The oncologist | 2024

von LeVee, A. | Wong, M. | Flores, S. | +4

6

Recent updates in the therapeutic uses of Pembrolizumab : a brief narrative review

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Silva, V. | Matos, C.

7

Rapid onset pembrolizumab-induced inflammatory arthritis diagnosed using musculoskeletal ultrasound

enthalten in: BMJ case reports | 2024

von Harnden, K. | Di Matteo, A. | Howell, K. | +1

8

Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination

enthalten in: Journal for immunotherapy of cancer | 2024

von Watson, R. | Ye, W. | Taylor, C. | +16

9

Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Milowsky, M. | O'Donnell, P. | Hoimes, C. | +20

10

Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy : TROPHY-U-01 Cohort 3

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Grivas, P. | Pouessel, D. | Park, C. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[770]